L-Arginine attenuates lipopolysaccharide-induced lung chemokine production

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 3 24-3, 2001, Pages

  Calkins, Casey M ^a   Bensard, Denis D ^a,b   Heimbach, Julie K ^a   Meng, Xianzhong ^a   Shames, Brian D ^a   Pulido, Edward J ^a   McIntyre Jr , Robert C ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Acute lung injury; Cytokine induced neutrophil chemoattractant 1; Inhibitory factor B; Macrophage inflammatory protein 2; Nitric oxide; Nitric oxide synthase; Nuclear factor B

Indexed keywords

ARGININE; CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; LEUKOCYTE; LUNG INJURY; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; REGULATORY MECHANISM;

EID: 0034998152     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.3.l400     Document Type: Article

References (58)

1. Ajuebor MN, Virag L, Flower RJ, Perretti M, and Szabo C. Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation. Immunology 95: 625-630, 1998.
2. Angele MK, Smail N, Knoferl MW, Ayala A, Cioffi WG, and Chaudry IH. L-Arginine restores splenocyte functions after trauma and hemorrhage potentially by improving splenic blood flow. Am J Physiol Cell Physiol 276: C145-C151, 1999.
3. Barnett CC Jr, Moore EE, Mierau GW, Partrick DA, Biffl WL, Elzi DJ, and Silliman CC. ICAM-1-CD18 interaction mediates neutrophil cytotoxicity through protease release. Am J Physiol Cell Physiol 274: C1634-C1644, 1998.
4. Biffl WL, Moore EE, Moore FA, and Barnett C. Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM)-1. J Surg Res 63: 328-332, 1996.
5. Blackwell TS, Blackwell TR, Holden EP, Christman BW, and Christman JW. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 157: 1630-1637, 1996.
6. Blackwell TS, Holden EP, Blackwell TR, DeLarco JE, and Christman JW. Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats: association with nuclear factor kappa B activation. Am J Respir Cell Mol Biol 11: 464-472, 1994.
7. Bless NM, Warner RL, Padgaonkar VA, Lentsch AB, Czermak BJ, Schmal H, Friedl HP, and Ward PA. Roles for C-X-C chemokines and C5a in lung injury after hindlimb ischemia-reperfusion. Am J Physiol Lung Cell Mol Physiol 276: L57-L63, 1999.
8. Brown Z, Robson RL, and Westwick J. L-Arginine/nitric oxide pathway: a possible signal transduction mechanism for the regulation of the chemokine IL-8 in human mesangial cells. Adv Exp Med Biol 351: 65-75, 1993.
9. Carey LA, Perkowski SZ, Lipsky CL, Cirelli RA, Spath JA Jr, and Gee MH. Neutrophil recruitment as a factor limiting injury or promoting recovery from acute lung injury. Am J Physiol Heart Circ Physiol 272: H279-H289, 1997.
10. Chollet-Martin S, Gatecel C, Kermarrec N, Gougerot-Pocidalo MA, and Payen DM. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 153: 985-990, 1996.
11. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
12. DelaTorre A, Schroeder RA, Punzalan C, and Kuo PC. Endotoxin-mediated S-nitrosylation of p50 alters NF-kappa B-dependent gene transcription in ANA-1 murine macrophages. J Immunol 162: 4101-4108, 1999.
13. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, and Haslett C. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341: 643-647, 1993.
14. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, and Rotstein OD. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation after lipopolysaccharide. J Immunol 161: 440-447, 1998.
15. Fowler AA III, Fisher BJ, Sweeney LB, Wallace TJ, Natarajan R, Ghosh SS, and Ghosh S. Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-kappaB binding to DNA: effects on endothelial function. Biochem Cell Biol 77: 201-208, 1999.
16. Fullerton DA, Eisenach JH, McIntyre RC Jr, Friese RS, Sheridan BC, Roe GB, Agrafojo J, Banerjee A, and Harken AH. Inhaled nitric oxide prevents pulmonary endothelial dysfunction after mesenteric ischemia-reperfusion. Am J Physiol Lung Cell Mol Physiol 271: L326-L331, 1996.
17. Fullerton DA, McIntyre RC Jr, Hahn AR, Agrafojo J, Koike K, Meng X, Banerjee A, and Harken AH. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 268: L1029-L1035, 1995.
18. Gagnon C, Leblond FA, and Filep JG. Peroxynitrite production by human neutrophils, monocytes and lymphocytes challenged with lipopolysaccharide. FEBS Lett 431: 107-110, 1998.
19. Gryglewski RJ, Wolkow PP, Uracz W, Janowska E, Bartus JB, Balbatun O, Patton S, Brovkovyeh V, and Malinski T. Protective role of pulmonary nitric oxide in the acute phase of endotoxemia in rats. Circ Res 82: 819-827, 1998.
20. Guidot DM, Hybertson BM, Kitlowski RP, and Repine JE. Inhaled NO prevents IL-1-induced neutrophil accumulation and associated acute edema in isolated rat lungs. Am J Physiol Lung Cell Mol Physiol 271: L225-L229, 1996.
21. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, and Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56: 559-564, 1994.
22. Henderson GS, Conary JT, Davidson JM, Stewart SJ, House FS, and McCurley TL. A reliable method for Northern blot analysis using synthetic oligonucleotide probes. Biotechniques 10: 190-197, 1991.
23. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, and Kubes P. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 11: 955-964, 1997.
24. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, Billiar TR, and Tweardy DJ. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 187: 917-928, 1998.
25. Hinder F, Stubbe HD, Van Aken H, Waurick R, Booke M, and Meyer J. Role of nitric oxide in sepsis-associated pulmonary edema. Am J Respir Crit Care Med 159: 252-257, 1999.
26. Katsuyama K, Shichiri M, Marumo F, and Hirata Y. NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α. Arterioscler Thromb Vasc Biol 18: 1796-1802, 1998.
27. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, and Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 41: 457-463, 1997.
28. Kristof AS, Goldberg P, Laubach V, and Hussain SN. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 158: 1883-1889, 1998.
29. Kubes P, Kurose I, and Granger DN. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am J Physiol Heart Circ Physiol 267: H931-H937, 1994.
30. Lefer AM and Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32: 743-751, 1996.
31. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, Huang PL, and Scalia R. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol Heart Circ Physiol 276: H1943-H1950, 1999.
32. Liu P, Xu B, Hock CE, Nagele R, Sun FF, and Wong PY. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am J Physiol Heart Circ Physiol 275: H2191-H2198, 1998.
33. Matthews JR, Botting CH, Panico M, Morris HR, and Hay RT. Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res 24: 2236-2242, 1996.
34. Meldrum DR, McIntyre RC, Sheridan BC, Cleveland JC Jr, Fullerton DA, and Harken AH. L-Arginine decreases alveolar macrophage proinflammatory monokine production during acute lung injury by a nitric oxide synthase-dependent mechanism. J Trauma 43: 888-893, 1997.
35. Meyrick B and Brigham KL. Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure: function relationships. Lab Invest 48: 458-470, 1983.
36. Mikawa K, Nishina K, Tamada M, Takao Y, Maekawa N, and Obara H. Aminoguanidine attenuates endotoxin-induced acute lung injury in rabbits. Crit Care Med 26: 905-911, 1998.
37. Moine P, McIntyre R, Schwartz MD, Kaneko D, Shenkar R, Le Tulzo Y, Moore EE, and Abraham E. NF-κB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13: 85-91, 2000.
38. Moine P, Shenkar R, Kaneko D, Le Tulzo Y, and Abraham E. Systemic blood loss affects NF-κB regulatory mechanisms in the lungs. Am J Physiol Lung Cell Mol Physiol 273: L185-L192, 1997.
39. Moncada S, Palmer RM, and Higgs EA. Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 38: 1709-1715, 1989.
40. Nathens AB, Bitar R, Davreux C, Bujard M, Marshall JC, Dackiw AP, Watson RW, and Rotstein OD. Pyrrolidine dithiocarbamate attenuates endotoxin-induced ALI. Am J Respir Cell Mol Biol 17: 608-616, 1997.
41. Numata M, Suzuki S, Miyazawa N, Miyashita A, Nagashima Y, Inoue S, Kaneko T, and Okubo T. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol 160: 3031-3037, 1998.
42. Ouaaz F, Li M, and Beg AA. A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immuneresponse genes and in Fas-induced cell death. J Exp Med 189: 999-1004, 1999.
43. Peng HB, Libby P, and Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-κB. J Biol Chem 270: 14214-14219, 1995.
44. Pulido EJ, Shames BD, Selzman CH, Barton HA, Banerjee A, Bensard DD, and McIntyre RC Jr. Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation. Am J Physiol Lung Cell Mol Physiol 277: L769-L776, 1999.
45. Sato Y, Walley KR, Klut ME, English D, D'Yachkova Y, Hogg JC, and van Eeden SF. Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression. Am J Respir Crit Care Med 159: 1469-1476, 1999.
46. Schmal H, Shanley TP, Jones ML, Friedl HP, and Ward PA. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol 156: 1963-1972, 1996.
47. Schreiber E, Matthias P, Muller MM, and Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts' prepared from a small number of cells. Nucleic Acids Res 17: 6419, 1989.
48. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, and Abraham E. Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 24: 1285-1292, 1996.
49. Shanley TP, Schmal H, Warner RL, Schmid E, Friedl HP, and Ward PA. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J Immunol 158: 3439-3448, 1997.
50. Sheridan BC, McIntyre RC, Agrafojo J, Meldrum DR, Meng X, and Fullerton DA. Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation. Am J Physiol Lung Cell Mol Physiol 271: L820-L828, 1996.
51. Sheridan BC, McIntyre RC Jr, Meldrum DR, and Fullerton DA. L-Arginine prevents lung neutrophil accumulation and preserves pulmonary endothelial function after endotoxin. Am J Physiol Lung Cell Mol Physiol 274: L337-L342, 1998.
52. Spiecker M, Darius H, Kaboth K, Hubner F, and Liao JK. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 63: 732-739, 1998.
53. Tang WW, Yi ES, Remick DG, Wittwer A, Yin S, Qi M, and Ulich TR. Intratracheal injection of endotoxin and cytokines. IX. Contribution of CD11a/ICAM-1 to neutrophil emigration. Am J Physiol Lung Cell Mol Physiol 269: L653-L659, 1995.
54. Thomassen MJ, Buhrow LT, Connors MJ, Kaneko FT, Erzurum SC, and Kavuru MS. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 17: 279-283, 1997.
55. Tracey WR, Nakane M, Basha F, and Carter G. In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitors. Can J Physiol Pharmacol 73: 665-669, 1995.
56. Tsao PS, Wang B, Buitrago R, Shyy JY, and Cooke JP. Nitric oxide regulates monocyte chemotactic protein-1. Circulation 96: 934-940, 1997.
57. Walley KR, McDonald TE, Higashimoto Y, and Hayashi S. Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury. Am J Respir Crit Care Med 160: 698-704, 1999.
58. Wizemann TM, Gardner CR, Laskin JD, Quinones S, Durham SK, Goller NL, Ohnishi ST, and Laskin DL. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J Leukoc Biol 56: 759-768, 1994.